BlackRock Health Sciences Trust II
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BMEZ research report →
Companywww.blackrock.com/us/individual/products/312196/blackrock-health-sciences-trust-ii-class
BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.
- CEO
- Xiang Liu
- IPO
- 2020
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $1.43B
- P/E
- 6.58
- P/S
- 18.95
- P/B
- 0.89
- EV/EBITDA
- 6.29
- Div Yield
- 8.03%
Profitability
- Gross Margin
- 89.28%
- Op Margin
- 305.20%
- Net Margin
- 288.16%
- ROE
- 14.30%
- ROIC
- 14.30%
Growth & Income
- Revenue
- $24.07M · 193.79%
- Net Income
- $23.45M · 17.17%
- EPS
- $1.77 · 22.92%
- Op Income
- $927.18K
- FCF YoY
- 104.63%
Performance & Tape
- 52W High
- $15.80
- 52W Low
- $13.67
- 50D MA
- $14.19
- 200D MA
- $14.67
- Beta
- 0.86
- Avg Volume
- 210.74K
Get TickerSpark's AI analysis on BMEZ
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 30, 26 | Liu Xiang | other | 523.331 |
| Jan 30, 26 | Liu Xiang | other | 1,026.693 |
| Jan 30, 26 | Liu Xiang | other | 777.922 |
| Jan 30, 26 | Liu Xiang | other | 254.591 |
| Jan 30, 26 | Liu Xiang | sell | 777.922 |
| Jan 30, 26 | Xie H Erin | other | 25,676.274 |
| Jan 30, 26 | Xie H Erin | other | 8,915.347 |
| Jan 30, 26 | Xie H Erin | other | 17,560.493 |
| Jan 30, 26 | Xie H Erin | other | 8,861.551 |
| Jan 30, 26 | Xie H Erin | sell | 25,676.274 |
Our BMEZ Coverage
We haven't published any research on BMEZ yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BMEZ Report →